⌕
Phathom Pharmaceuticals · PHAT · Nasdaq
Tenet 33 · Weak
Compare
$5.30−3.64%At closeTenet 33 · Weak
$5.30−0.20 (−3.64%)
At close: Nov 18, 2026, 4:00 PM ET· Nasdaq · USD

Phathom Pharmaceuticals (PHAT) Institutional Ownership

13F filers reported holding 87.8% of Phathom Pharmaceuticals (PHAT) shares as of Sep 30, 2026, across 164 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
87.8%
Sep 30, 2026
13F filers
164
quarter ended Sep 30, 2026
13F value
$521.1M
71.4M shares
Quarter's fund flow
Mild accumulation
26 new · 25 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (26 new · 72 increased · 38 reduced · 25 closed · 3 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 50 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 164 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 50 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 6, 2026Narula SanjeevChief Financial & Bus. OfficerDisposed · Tax withholding13,485$6.78↗
Sep 3, 2026Breedlove Robert CharlesPrincipal Accounting OfficerDisposed · Tax withholding460$9.05↗
Jul 14, 2026Breedlove Robert CharlesPrincipal Accounting OfficerDisposed · Tax withholding1,555$11.04↗
May 22, 2026Parikh AsitdirectorDisposed · Gift28,000—↗
May 22, 2026Parikh AsitdirectorAcquired · Gift28,000—↗
May 20, 2026Parikh AsitdirectorAcquired · Option exercise17,500$4.95↗
May 20, 2026Parikh AsitdirectorDisposed · Disposition to issuer17,500—↗
May 19, 2026Parikh AsitdirectorAcquired · Grant / award24,122—↗
May 19, 2026Topper James NdirectorAcquired · Grant / award24,122—↗
May 19, 2026Stenhouse MarkdirectorAcquired · Grant / award24,122—↗
May 19, 2026FIELDS HEIDIdirectorAcquired · Grant / award24,122—↗
May 19, 2026COLA MICHAEL FdirectorAcquired · Grant / award24,122—↗
May 19, 2026KARBE FRANKdirectorAcquired · Grant / award24,122—↗
May 19, 2026Schroeder Theodore RdirectorAcquired · Grant / award24,122—↗
Mar 10, 2026Parikh AsitdirectorDisposed · Gift40,000—↗
Mar 10, 2026Parikh AsitdirectorAcquired · Gift40,000—↗
Feb 27, 2026Breedlove Robert CharlesPrincipal Accounting OfficerAcquired · Grant / award13,000—↗
Feb 27, 2026Breedlove Robert CharlesPrincipal Accounting OfficerAcquired · Grant / award2,790—↗
Feb 27, 2026Breedlove Robert CharlesPrincipal Accounting OfficerDisposed · Tax withholding964$12.56↗
Feb 27, 2026Breedlove Robert CharlesPrincipal Accounting OfficerDisposed · Tax withholding414$12.56↗

* Holdings as reported for Sep 30, 2026, 50 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Phathom Pharmaceuticals do institutions hold?

13F filers reported holding 87.8% of Phathom Pharmaceuticals' shares as of Sep 30, 2026, across 164 filers.

How many 13F filers hold Phathom Pharmaceuticals?

Phathom Pharmaceuticals was held by 164 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.